Implements methods for inference on potential waning of vaccine efficacy and for estimation of vaccine efficacy at a user-specified time after vaccination based on data from a randomized, double-blind, placebo-controlled vaccine trial in which participants may be unblinded and placebo subjects may be crossed over to the study vaccine. The methods also allow adjustment for possible confounding via inverse probability weighting through specification of models for the trial entry process, unblinding mechanisms, and the probability an unblinded placebo participant accepts study vaccine: Tsiatis, A. A. and Davidian, M. (2022) <doi:10.1111/biom.13509>.
Package details |
|
---|---|
Author | Marie Davidian [aut], A.A. Tsiatis [aut], Shannon T. Holloway [aut, cre] |
Maintainer | Shannon T. Holloway <shannon.t.holloway@gmail.com> |
License | GPL-2 |
Version | 1.4 |
Package repository | View on CRAN |
Installation |
Install the latest version of this package by entering the following in R:
|
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.